Hedge funds waive fees for charity

A new investment trust from JP Morgan Cazenove is in the pipeline that will invest in blue-chip managers and donate 1% a year to charity, Financial News can reveal

JP Morgan Cazenove is preparing to launch an innovative investment trust that will allocate money to blue-chip fund managers and donate 1% a year to cancer charities, Financial News can reveal.

BACIT, which stands for Battle Against Cancer Investment Trust, "will invest in leading long-only and alternative investment funds across multiple asset classes," according to a company presentation seen by Financial News. It is understood that the London Stock Exchange-listed company may come to market within the next few weeks.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump